State Of Wisconsin Investment Board Oncocyte Corp Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.15 - $2.25 $67,390 - $131,850	-58,600 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$2.04 - $3.59 $209,916 - $369,411	-102,900 Reduced 63.72%	58,600 $127,000
Q3 2021 Nov 12, 2021	BUY	$3.53 - $5.89 $213,639 - $356,468	60,521 Added 59.93%	161,500 $575,000
Q2 2021 Aug 12, 2021	BUY	$3.77 - $6.0 $131,493 - $209,274	34,879 Added 52.77%	100,979 $580,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $157,979 - $429,650	66,100 New	66,100 $343,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $305M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.